ArticleOncoTargets and therapy2014

Doxorubicin-conjugated bacteriophages carrying anti-MHC class I chain-related A for targeted cancer therapy in vitro.

Achara Phumyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.